Physician profile
Bobby Palmos
NPI 1891315669
$4,979.42
in general payments reported to CMS, 2019-2025
31 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $457 · 2021: $471 · 2022: $1,271 · 2023: $1,607 · 2024: $785 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,780 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,779.96 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,000.00 | 2022-2023 | Davinci Xi |
| Medical Device Business Services, INC. | $305.00 | 2020 | |
| Kci USA, INC. | $226.24 | 2020-2023 | Prevena, V.A.C. Veraflo, Abthera |
| Allergan, INC. | $217.57 | 2021-2022 | |
| Urgo Medical North America, LLC | $205.17 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Medtronic, INC. | $202.30 | 2023-2025 | Signia |
| Ethicon US, LLC | $198.05 | 2020-2024 | Echelon Flex, Echelon; Endopath, Enseal X1 |
| Abbvie INC. | $192.26 | 2023-2024 | |
| Stryker Corporation | $179.89 | 2020-2023 | Spy-Phi System |
| Kerecis Limited | $163.13 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $123.23 | 2024-2025 | Restrata Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $121.79 | 2022-2024 | Andexxa |
| Integra Lifesciences Corporation | $117.24 | 2023 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
| Solventum Corporation | $103.69 | 2024-2025 | Prevena, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Csl Behring | $82.02 | 2020-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $71.01 | 2023-2024 | Xenosure Biologic Patch, Pruitt F3 Carotid Shunt |
| Tela Bio, INC. | $61.25 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Janssen Pharmaceuticals, INC | $50.68 | 2021-2022 | |
| Smith+Nephew, INC. | $49.54 | 2025 | Stravix, Pico |
| Pacira Pharmaceuticals Incorporated | $47.90 | 2021-2022 | |
| Avita Medical Americas, LLC | $42.48 | 2024 | |
| Pfizer INC. | $42.34 | 2021-2022 | |
| Teleflex LLC | $25.09 | 2025 | Quikclot |
| Davol INC. | $23.13 | 2023 | Arista Ah Flexitip |
| Avanos Medical | $21.43 | 2022 | |
| Boston Scientific Corporation | $20.46 | 2024 | Spyglass Discover |
| Merck Sharp & Dohme LLC | $17.97 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $17.59 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.58 | 2023 | Eliquis |
| Cardiovascular Systems INC. | $16.96 | 2021 | |
| Axogen | $16.43 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Palmos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.